Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : STOCKS WITH ATTITUDE TEAM - FA/TA AND EVERYTHING ELSE -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (770)	12/23/1997 10:03:00 PM
From: Instock	Read Replies (1) \| Respond to of 2377

Anybody see any good AFTER the MARKET close News? Good or Bad News? When I get homelater tonight, I will start checking to see if there are any good late News stories that might make good plays Wednesday. If you know of any, please share. Take a look at SMMT, but I think it has probably already had its play anyway. Instock ( He's hereeeeeee )

To: Sergio H who wrote (770)	12/24/1997 9:31:00 AM
From: David Graham	Respond to of 2377

Sergio, Fundamentals still look good, although growth appears to be back to 30 to 35 percent from 42. Alex Brown just dropped to buy from strong buy. Gotta find some money this morning as I don't want to carryu a margin leaving the year. Grammy

To: Sergio H who wrote (770)	12/24/1997 10:35:00 AM
From: Frank Fontaine	Respond to of 2377

American Bio Medica Stock Begins Trading on the Nasdaq SmallCap Market PR Newswire - December 24, 1997 10:01 ABMC %MTC V%PRN P%PRN Trading Commences at Market Opening ANCRAMDALE, N.Y., Dec. 24 /PRNewswire/ -- American Bio Medica Corporation (Nasdaq: ABMC) today announced that its stock began trading on The Nasdaq SmallCap Market(SM) this morning. "We are extremely pleased for our stock to begin trading on The Nasdaq SmallCap Market," commented American Bio Medica President Stan Cipkowski. "This listing not only adds credibility to the Company but creates the opportunity to increase our shareholder base and gain valuable analyst coverage. "Our listing is especially gratifying for everyone involved here at American Bio Medica," continued Cipkowski. "We sincerely appreciate our shareholders' confidence and look forward to reporting continued appreciation of our long-term value as we expand within the global substance abuse testing industry." Nasdaq, the fastest growing stock market in the United States, began operating in 1971 and was the world's first electronic stock market. Today, it serves millions of investors around the globe, has more listed companies than any other market in the world, and, in terms of dollar volume trading, is the world's second largest stock market. Companies listed on Nasdaq are separated into two tiers -- The Nasdaq SmallCap Market(SM), for small- to medium-sized companies, and the Nasdaq National Market(R), for larger companies with higher capitalization. American Bio Medica Corporation develops, manufactures, and markets rapid, low-cost, and easy-to-use diagnostic kits and support services to substance abuse testing markets worldwide. In field tests conducted last year, ABMC's drug detection strip demonstrated 100% correlation with the results produced by the SYVA EMIT II standard laboratory test. Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence upon third-party suppliers, intellectual property rights and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. For further information, updates, and a current report, see www.otcfn.com/abmc SOURCE American Bio Medica Corporation /CONTACT: Geoffrey J. Eiten, President of OTC Financial Network, 888-433-3077, 781-444-6100 or Stan Cipkowski, President of American Bio Medica, 518-329-4485/ /Web site: otcfn.com (ABMC) CO: American Bio Medica Corporation ST: New York IN: MTC SU: Happy Holidays, Frank.